XML 98 R88.htm IDEA: XBRL DOCUMENT v2.4.0.8
Information as to Operating Segments and Foreign and Domestic Operations (Details) (USD $)
3 Months Ended 12 Months Ended
Jul. 31, 2013
Apr. 30, 2013
Jan. 31, 2013
Oct. 31, 2012
Jul. 31, 2012
Apr. 30, 2012
Jan. 31, 2012
Oct. 31, 2011
Jul. 31, 2013
Jul. 31, 2012
Jul. 31, 2011
Concentration risk                      
Consolidated net sales $ 113,973,000 $ 105,009,000 $ 106,363,000 $ 99,681,000 $ 98,693,000 $ 97,238,000 $ 97,297,000 $ 93,262,000 $ 425,026,000 $ 386,490,000 $ 321,651,000
Water Purification and Filtration
                     
Concentration risk                      
Consolidated net sales                 134,196,000 114,609,000 104,308,000
Dialysis
                     
Concentration risk                      
Consolidated net sales                 33,148,000 35,644,000 38,055,000
Healthcare Disposables
                     
Concentration risk                      
Consolidated net sales                 90,904,000 76,229,000 70,202,000
Segment sales | Customer concentration | Water Purification and Filtration | DaVita
                     
Concentration risk                      
Concentration risk (as a percent)                 23.90%    
Segment sales | Customer concentration | Water Purification and Filtration | Another large dialysis provider
                     
Concentration risk                      
Concentration risk (as a percent)                 24.60%    
Segment sales | Customer concentration | Dialysis | DaVita
                     
Concentration risk                      
Concentration risk (as a percent)                 36.40%    
Segment sales | Customer concentration | Healthcare Disposables | Four customers
                     
Concentration risk                      
Number of customers concentration risk                 4    
Concentration risk (as a percent)                 54.00%    
Net sales | Customer concentration | DaVita
                     
Concentration risk                      
Concentration risk (as a percent)                 10.40% 10.20%  
Consolidated net sales                 $ 44,204,000 $ 39,300,000  
Net sales | Customer concentration | DaVita and another large dialysis provider
                     
Concentration risk                      
Number of customers concentration risk                 2    
Concentration risk (as a percent)                 18.20%    
Net sales | Customer concentration | Four customers
                     
Concentration risk                      
Concentration risk (as a percent)                 11.60%